Plasma Cobalamin and Transcobalamin in Patients with Primary Carcinoma of the Liver

Of 37 patients with histologically verified hepatocellular carcinoma (HCC) from Bangkok, Thailand, 34 had raised values of plasma cobalamin, and 1 presented with a markedly increased value of plasma transcobalamin I (TC I). One patient with clinical malignancy of the liver, not proven histologically...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scandinavian journal of gastroenterology 1983-03, Vol.18 (2), p.229-232
Hauptverfasser: Nörredam, K., Chainuvati, T., Gimsing, P., Hippe, E., Viranuvatti, V.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 232
container_issue 2
container_start_page 229
container_title Scandinavian journal of gastroenterology
container_volume 18
creator Nörredam, K.
Chainuvati, T.
Gimsing, P.
Hippe, E.
Viranuvatti, V.
description Of 37 patients with histologically verified hepatocellular carcinoma (HCC) from Bangkok, Thailand, 34 had raised values of plasma cobalamin, and 1 presented with a markedly increased value of plasma transcobalamin I (TC I). One patient with clinical malignancy of the liver, not proven histologically to be HCC, had a raised plasma cobalamin value and a markedly increased value of TC I. From our own studies and from studies in the literature we find circumstantial evidence that TC I occasionally is produced by the malignant liver cells in HCC.
doi_str_mv 10.3109/00365528309181588
format Article
fullrecord <record><control><sourceid>informahealthcare</sourceid><recordid>TN_cdi_informahealthcare_journals_10_3109_00365528309181588</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3109_00365528309181588</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1008-46bff51874a1b5f53b90bf7983e42a238d3ce93334e0c3bc27af7439eb86e0063</originalsourceid><addsrcrecordid>eNplUNtKxDAQDaLguvoBvuUHqpNO0yT4JMUbLLjg-lwm2YRmaVNIq-LfW1F8EQ4cOJcZOIxdCrhCAeYaAGspS41ghBZS6yO2EhLKQinQx2z17RdLQJyys2k6AIBUlVmxl21P00C8GS31NMTEKe35LlOa3J-0YEtz9Gme-EecO77NcaD8yRvKLqZx6Y-Bz53nm_ju8zk7CdRP_uKX1-z1_m7XPBab54en5nZTOAGgi6q2IUihVUXCyiDRGrBBGY2-KqlEvUfnDSJWHhxaVyoKqkLjra49QI1rdvNzN6Yw5oE6T_3cOcq-PYxvOS2_WwHt9z7tv33wC4SYWE8</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Plasma Cobalamin and Transcobalamin in Patients with Primary Carcinoma of the Liver</title><source>Taylor &amp; Francis Medical Library - CRKN</source><source>Taylor &amp; Francis Journals Complete</source><creator>Nörredam, K. ; Chainuvati, T. ; Gimsing, P. ; Hippe, E. ; Viranuvatti, V.</creator><creatorcontrib>Nörredam, K. ; Chainuvati, T. ; Gimsing, P. ; Hippe, E. ; Viranuvatti, V.</creatorcontrib><description>Of 37 patients with histologically verified hepatocellular carcinoma (HCC) from Bangkok, Thailand, 34 had raised values of plasma cobalamin, and 1 presented with a markedly increased value of plasma transcobalamin I (TC I). One patient with clinical malignancy of the liver, not proven histologically to be HCC, had a raised plasma cobalamin value and a markedly increased value of TC I. From our own studies and from studies in the literature we find circumstantial evidence that TC I occasionally is produced by the malignant liver cells in HCC.</description><identifier>ISSN: 0036-5521</identifier><identifier>EISSN: 1502-7708</identifier><identifier>DOI: 10.3109/00365528309181588</identifier><language>eng</language><publisher>Informa UK Ltd</publisher><ispartof>Scandinavian journal of gastroenterology, 1983-03, Vol.18 (2), p.229-232</ispartof><rights>1983 Informa UK Ltd 1983</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1008-46bff51874a1b5f53b90bf7983e42a238d3ce93334e0c3bc27af7439eb86e0063</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.3109/00365528309181588$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.3109/00365528309181588$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,61221,61256,61402,61437</link.rule.ids></links><search><creatorcontrib>Nörredam, K.</creatorcontrib><creatorcontrib>Chainuvati, T.</creatorcontrib><creatorcontrib>Gimsing, P.</creatorcontrib><creatorcontrib>Hippe, E.</creatorcontrib><creatorcontrib>Viranuvatti, V.</creatorcontrib><title>Plasma Cobalamin and Transcobalamin in Patients with Primary Carcinoma of the Liver</title><title>Scandinavian journal of gastroenterology</title><description>Of 37 patients with histologically verified hepatocellular carcinoma (HCC) from Bangkok, Thailand, 34 had raised values of plasma cobalamin, and 1 presented with a markedly increased value of plasma transcobalamin I (TC I). One patient with clinical malignancy of the liver, not proven histologically to be HCC, had a raised plasma cobalamin value and a markedly increased value of TC I. From our own studies and from studies in the literature we find circumstantial evidence that TC I occasionally is produced by the malignant liver cells in HCC.</description><issn>0036-5521</issn><issn>1502-7708</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNplUNtKxDAQDaLguvoBvuUHqpNO0yT4JMUbLLjg-lwm2YRmaVNIq-LfW1F8EQ4cOJcZOIxdCrhCAeYaAGspS41ghBZS6yO2EhLKQinQx2z17RdLQJyys2k6AIBUlVmxl21P00C8GS31NMTEKe35LlOa3J-0YEtz9Gme-EecO77NcaD8yRvKLqZx6Y-Bz53nm_ju8zk7CdRP_uKX1-z1_m7XPBab54en5nZTOAGgi6q2IUihVUXCyiDRGrBBGY2-KqlEvUfnDSJWHhxaVyoKqkLjra49QI1rdvNzN6Yw5oE6T_3cOcq-PYxvOS2_WwHt9z7tv33wC4SYWE8</recordid><startdate>198303</startdate><enddate>198303</enddate><creator>Nörredam, K.</creator><creator>Chainuvati, T.</creator><creator>Gimsing, P.</creator><creator>Hippe, E.</creator><creator>Viranuvatti, V.</creator><general>Informa UK Ltd</general><scope/></search><sort><creationdate>198303</creationdate><title>Plasma Cobalamin and Transcobalamin in Patients with Primary Carcinoma of the Liver</title><author>Nörredam, K. ; Chainuvati, T. ; Gimsing, P. ; Hippe, E. ; Viranuvatti, V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1008-46bff51874a1b5f53b90bf7983e42a238d3ce93334e0c3bc27af7439eb86e0063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nörredam, K.</creatorcontrib><creatorcontrib>Chainuvati, T.</creatorcontrib><creatorcontrib>Gimsing, P.</creatorcontrib><creatorcontrib>Hippe, E.</creatorcontrib><creatorcontrib>Viranuvatti, V.</creatorcontrib><jtitle>Scandinavian journal of gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nörredam, K.</au><au>Chainuvati, T.</au><au>Gimsing, P.</au><au>Hippe, E.</au><au>Viranuvatti, V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma Cobalamin and Transcobalamin in Patients with Primary Carcinoma of the Liver</atitle><jtitle>Scandinavian journal of gastroenterology</jtitle><date>1983-03</date><risdate>1983</risdate><volume>18</volume><issue>2</issue><spage>229</spage><epage>232</epage><pages>229-232</pages><issn>0036-5521</issn><eissn>1502-7708</eissn><abstract>Of 37 patients with histologically verified hepatocellular carcinoma (HCC) from Bangkok, Thailand, 34 had raised values of plasma cobalamin, and 1 presented with a markedly increased value of plasma transcobalamin I (TC I). One patient with clinical malignancy of the liver, not proven histologically to be HCC, had a raised plasma cobalamin value and a markedly increased value of TC I. From our own studies and from studies in the literature we find circumstantial evidence that TC I occasionally is produced by the malignant liver cells in HCC.</abstract><pub>Informa UK Ltd</pub><doi>10.3109/00365528309181588</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0036-5521
ispartof Scandinavian journal of gastroenterology, 1983-03, Vol.18 (2), p.229-232
issn 0036-5521
1502-7708
language eng
recordid cdi_informahealthcare_journals_10_3109_00365528309181588
source Taylor & Francis Medical Library - CRKN; Taylor & Francis Journals Complete
title Plasma Cobalamin and Transcobalamin in Patients with Primary Carcinoma of the Liver
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T08%3A23%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-informahealthcare&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20Cobalamin%20and%20Transcobalamin%20in%20Patients%20with%20Primary%20Carcinoma%20of%20the%20Liver&rft.jtitle=Scandinavian%20journal%20of%20gastroenterology&rft.au=N%C3%B6rredam,%20K.&rft.date=1983-03&rft.volume=18&rft.issue=2&rft.spage=229&rft.epage=232&rft.pages=229-232&rft.issn=0036-5521&rft.eissn=1502-7708&rft_id=info:doi/10.3109/00365528309181588&rft_dat=%3Cinformahealthcare%3E10_3109_00365528309181588%3C/informahealthcare%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true